HUP0402293A2 - Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására - Google Patents
Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállításáraInfo
- Publication number
- HUP0402293A2 HUP0402293A2 HU0402293A HUP0402293A HUP0402293A2 HU P0402293 A2 HUP0402293 A2 HU P0402293A2 HU 0402293 A HU0402293 A HU 0402293A HU P0402293 A HUP0402293 A HU P0402293A HU P0402293 A2 HUP0402293 A2 HU P0402293A2
- Authority
- HU
- Hungary
- Prior art keywords
- coated granules
- fexofenadine
- preparation
- tablets containing
- orodispersible tablets
- Prior art date
Links
- 239000007931 coated granule Substances 0.000 title abstract 4
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003592 fexofenadine Drugs 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
Abstract
A találmány tárgya szájban diszpergálódni képes tabletta, amely aszájüregben nyállal való érintkezéskor képes szétesni kevesebb, mint60 másodpercen belül, könnyen lenyelhető szuszpenzió kialakításával,és amely a következőket tartalmazza: (i) fexofenadin vagy legalább egyvalamely gyógyszerészetileg elfogadható sója bevonatos granulátumokformájában, és (ii) excipiensek keveréke, amely legalább egydezintegrálószert, egy oldható hígítóanyagot és csúsztatóanyagottartalmaz. Az oltalmi körbe tartoznak még a fexofenadint vagy valamelygyógyszerészetileg elfogadható sóját tartalmazó bevonatosgranulátumok, valamint a tabletták és a bevonatos granulátumokelőállítására szolgáló eljárások is. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/995,975 US6723348B2 (en) | 2001-11-16 | 2001-11-16 | Orodispersible tablets containing fexofenadine |
PCT/EP2002/014917 WO2003041683A2 (en) | 2001-11-16 | 2002-11-14 | Orodispersible tablets containing fexofenadine |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0402293A2 true HUP0402293A2 (hu) | 2005-02-28 |
HUP0402293A3 HUP0402293A3 (en) | 2011-05-30 |
HU229570B1 HU229570B1 (en) | 2014-02-28 |
Family
ID=25542381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402293A HU229570B1 (en) | 2001-11-16 | 2002-11-14 | Orodispersible tablets containing fexofenadine |
Country Status (14)
Country | Link |
---|---|
US (2) | US6723348B2 (hu) |
EP (1) | EP1458387B1 (hu) |
JP (2) | JP2005513008A (hu) |
KR (2) | KR101020809B1 (hu) |
CN (2) | CN101849917A (hu) |
AT (1) | ATE335483T1 (hu) |
AU (1) | AU2002356786A1 (hu) |
CA (1) | CA2466580C (hu) |
DE (1) | DE60213861T2 (hu) |
ES (1) | ES2269817T3 (hu) |
HK (1) | HK1069340A1 (hu) |
HU (1) | HU229570B1 (hu) |
PL (1) | PL368610A1 (hu) |
WO (1) | WO2003041683A2 (hu) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
US7118765B2 (en) * | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
FR2834889B1 (fr) * | 2002-01-18 | 2004-04-02 | Roquette Freres | Forme pharmaceutique solide orodispersible |
MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
EP1476139B1 (en) | 2002-02-21 | 2017-05-17 | Valeant Pharmaceuticals Luxembourg S.à.r.l. | Controlled release dosage forms |
BRPI0308445A2 (pt) * | 2002-03-08 | 2016-08-02 | M S Ind Swift Ltd | complexos de rápida dissolução, diretamente compressíveis, sem sabor e formulações farmacêuticas dos mesmos |
US20050147670A1 (en) * | 2002-05-29 | 2005-07-07 | Impax Laboratories Inc. | Oral disintegrating dosage forms |
US20030228370A1 (en) * | 2002-06-11 | 2003-12-11 | Michel Serpelloni | Orodispersible solid pharmaceutical form |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
ES2298637T3 (es) * | 2003-03-07 | 2008-05-16 | Ind-Swift Limited | Complejos sin sabor, directamente compresibles, de disolucion rapida y formulaciones farmaceuticas de los mismos. |
PT1606261E (pt) | 2003-03-10 | 2010-01-11 | Nycomed Gmbh | Novo processo para a preparação de roflumilast |
US20040192660A1 (en) * | 2003-03-12 | 2004-09-30 | Mullally John P. | Protocol for improving vision |
WO2004080414A2 (en) * | 2003-03-12 | 2004-09-23 | Mullally John P | Composition and method for treating inflammations by reducing c-reactive protein |
FR2857263B1 (fr) * | 2003-07-09 | 2005-09-09 | Sanofi Synthelabo | Nouvelle composition pharmaceutique solide comprenant de l'amisulpride |
US20060172005A1 (en) * | 2003-07-10 | 2006-08-03 | Kyowa Hakko Kogyo Co.,Ltd. | Tablet and process for producing the same |
US20050065183A1 (en) * | 2003-07-31 | 2005-03-24 | Indranil Nandi | Fexofenadine composition and process for preparing |
US7838029B1 (en) | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
WO2005062722A2 (en) * | 2003-11-21 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Fexofenadine containing pharmaceutical formulation |
US20050142203A1 (en) * | 2003-12-30 | 2005-06-30 | Grant Heinicke | Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same |
EP1737433B1 (en) * | 2004-04-12 | 2007-11-14 | Pfizer Products Incorporated | Taste-masked drugs in rupturing multiparticulates |
EP1621187A1 (en) * | 2004-07-26 | 2006-02-01 | AstraZeneca AB | Pharmaceutical multiparticulate tablet formulations and process for their preparation |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US20060127479A1 (en) * | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
CA2583548A1 (en) * | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
US20060105039A1 (en) | 2004-10-21 | 2006-05-18 | Jin-Wang Lai | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
WO2006045152A1 (en) * | 2004-10-29 | 2006-05-04 | Mayne Pharma International Pty Ltd | Improved tabletting process |
US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
PT2377557T (pt) | 2004-11-24 | 2017-02-07 | Meda Pharmaceuticals Inc | Composições que compreendem azelastina e seus métodos de utilização |
EP2258350B1 (en) * | 2005-03-16 | 2014-12-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US20060275364A1 (en) * | 2005-05-26 | 2006-12-07 | Ahmed Salah U | Flexible Solid Dosage Forms and Methods of Making and Using the Same |
MX2008001645A (es) * | 2005-08-05 | 2008-04-07 | Lupin Ltd | Composiciones de fexofendina en suspension farmaceutica oral. |
US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
FR2894475B1 (fr) * | 2005-12-14 | 2008-05-16 | Servier Lab | Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine |
DOP2006000274A (es) * | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
ES2699444T3 (es) | 2006-04-04 | 2019-02-11 | Kg Acquisition Llc | Formas de dosificación oral que incluyen un agente antiplaquetario y un inhibidor ácido |
US20070238942A1 (en) * | 2006-04-10 | 2007-10-11 | Esophamet Corp. | Apparatus and method for detecting gastroesophageal reflux disease (gerd) |
US11116728B2 (en) | 2006-11-30 | 2021-09-14 | Bend Research, Inc. | Multiparticulates of spray-coated drug and polymer on a meltable core |
US10357462B2 (en) * | 2006-11-30 | 2019-07-23 | Ben Research, Inc. | Multiparticulates of spray-coated drug and polymer on a meltable core |
US20080152870A1 (en) * | 2006-12-22 | 2008-06-26 | Katsunori Takada | Transparent electrically-conductive hard-coated substrate and method for producing the same |
WO2008089773A1 (fr) * | 2007-01-22 | 2008-07-31 | Crd Saidal | Formulation d'une matrice a desintegration rapide |
JP5766899B2 (ja) * | 2007-04-11 | 2015-08-19 | ニプロ株式会社 | 口腔内崩壊剤及びその製造方法 |
ES2646112T3 (es) * | 2007-06-06 | 2017-12-12 | Basf Se | Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente |
US20100184785A1 (en) * | 2007-06-06 | 2010-07-22 | Basf Se | Pharmaceutical formulation for the production of chewable tablets and lozenges |
ES2639130T3 (es) * | 2007-06-06 | 2017-10-25 | Basf Se | Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración |
US8685457B2 (en) | 2007-06-06 | 2014-04-01 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
RU2436484C2 (ru) * | 2007-06-07 | 2011-12-20 | КТ энд ДЖИ КОРПОРЕЙШН | Сигаретный фильтр, содержащий растительный материал, и сигарета |
US8293337B2 (en) * | 2008-06-23 | 2012-10-23 | Cornell University | Multiplexed electrospray deposition method |
US8343978B2 (en) * | 2008-08-04 | 2013-01-01 | Adds Pharmaceuticals Llc | Fast onset orodispersable tablets |
PL2328539T3 (pl) | 2008-09-25 | 2018-09-28 | Isp Investments Llc | Gładka tabletkowa kompozycja powlekająca z wysoką zawartością ciał stałych |
KR101753411B1 (ko) * | 2008-11-25 | 2017-07-03 | 미쓰비시 타나베 파마 코퍼레이션 | 구강 내 속붕괴성정 및 그의 제조 방법 |
CN101822646B (zh) * | 2009-03-06 | 2013-04-17 | 北京本草天源药物研究院 | 一种盐酸非索非那定口腔崩解片及其制备方法 |
JP5713544B2 (ja) * | 2009-07-30 | 2015-05-07 | 杏林製薬株式会社 | イミダフェナシン含有口腔内速崩錠 |
CN102958515A (zh) * | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
CN102711737A (zh) * | 2009-12-28 | 2012-10-03 | 尼普洛株式会社 | 品质提高的口服制剂 |
FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
CN101836965A (zh) * | 2010-05-27 | 2010-09-22 | 北京万全阳光医药科技有限公司 | 一种含有非索非那定或其盐的口腔崩解片及其制备方法 |
JP4803686B2 (ja) * | 2010-08-31 | 2011-10-26 | 協和発酵キリン株式会社 | 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠 |
CA2836865C (en) * | 2011-05-25 | 2018-02-27 | Taiho Pharmaceutical Co., Ltd. | Dry-coated tablet containing tegafur, gimeracil and oteracil potassium |
PT2714712T (pt) | 2011-06-01 | 2016-11-08 | Estetra Sprl | Processo para a produção de intermediários de estetrol |
KR101994805B1 (ko) | 2011-06-01 | 2019-07-01 | 에스테트라 에스.피.알.엘. | 에스테트롤 중간체의 제조 방법 |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
JP6245677B2 (ja) * | 2012-01-20 | 2017-12-13 | ニプロ株式会社 | 口腔内崩壊錠 |
JP6176840B2 (ja) * | 2012-06-29 | 2017-08-09 | 高田製薬株式会社 | フェキソフェナジン顆粒製剤及びその製造方法 |
CN102949371B (zh) * | 2012-09-24 | 2014-06-25 | 黄法 | 一种耐水型薄膜包衣组合物及其应用 |
CN102885791B (zh) * | 2012-09-24 | 2015-03-04 | 浙江万晟药业有限公司 | 一种制备盐酸非索非那定口腔崩解片的方法 |
FR2999937B1 (fr) * | 2012-12-21 | 2015-01-09 | Sanofi Sa | Unite solide a haute teneur en fexofenadine et son procede de preparation |
RU2015132902A (ru) * | 2013-01-07 | 2017-02-09 | Сам-А Фарм. Ко., Лтд. | Новый быстрорастворимый состав гранул с улучшенной растворимостью |
AR094761A1 (es) | 2013-02-14 | 2015-08-26 | Sanofi Sa | Composición farmacéutica para administración oral que comprende fexofenadina y proceso para preparar la misma |
CA2900597C (en) * | 2013-02-14 | 2021-11-02 | Sanofi | Chewable composition for oral administration and process for preparing thereof |
TWI659752B (zh) * | 2013-03-26 | 2019-05-21 | 日商橘生藥品工業股份有限公司 | 經遮蔽西羅多辛(Silodosin)苦味之經口投與製劑 |
JP6184727B2 (ja) * | 2013-04-15 | 2017-08-23 | ロート製薬株式会社 | 医薬組成物 |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
MX369315B (es) | 2013-10-07 | 2019-11-05 | Impax Laboratories Inc | Formulaciones muco-adhesivas de liberacion controlada de levodopa y/o esteres de levodopa y sus usos. |
CN103610645B (zh) * | 2013-11-25 | 2016-05-11 | 浙江万晟药业有限公司 | 一种非索非那定盐酸盐的药物组合物及制备方法 |
US20170182070A1 (en) | 2014-10-08 | 2017-06-29 | Mayne Pharma International Pty Ltd. | Controlled Release Doxycycline |
EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
CN104687178A (zh) * | 2015-03-13 | 2015-06-10 | 上海益力健营养品有限公司 | 一种可直接口服的固体饮料及其制备方法 |
JP6128160B2 (ja) * | 2015-05-07 | 2017-05-17 | ニプロ株式会社 | 口腔内崩壊錠の製造方法 |
ES2800774T3 (es) | 2015-06-18 | 2021-01-04 | Estetra Sprl | Unidad de dosificación orodispersable que contiene un componente de estetrol |
ES2877186T3 (es) | 2015-06-18 | 2021-11-16 | Estetra Sprl | Comprimido orodispersable que contiene estetrol |
CN107750157B (zh) | 2015-06-18 | 2021-07-13 | 埃斯特拉私人有限责任公司 | 含雌四醇的口腔分散片剂 |
MX2017016276A (es) | 2015-06-18 | 2018-06-19 | Mithra Pharmaceuticals S A | Unidad de dosificacion orodispersable que contiene un componente estetrol. |
EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
ITUA20163981A1 (it) | 2016-05-31 | 2017-12-01 | Zambon Spa | Composizioni farmaceutiche comprendenti safinamide |
CN106137989A (zh) * | 2016-07-20 | 2016-11-23 | 南通雅本化学有限公司 | 一种基于盐酸非索非那定的药物组合物 |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
JP6410895B2 (ja) * | 2017-07-26 | 2018-10-24 | ロート製薬株式会社 | 医薬組成物 |
CN108267442A (zh) * | 2018-01-08 | 2018-07-10 | 云南商测质量检验技术服务有限公司 | 一种二氧化硫快速检测试剂及其制备方法 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
KR102222271B1 (ko) | 2020-10-15 | 2021-03-04 | (주)알피바이오 | 펙소페나딘 가용화 조성물 |
WO2023126637A1 (en) * | 2021-12-29 | 2023-07-06 | Opella Healthcare Group Sas | Compositions containing fexofenadine |
GB202212656D0 (en) | 2022-08-31 | 2022-10-12 | Novumgen Ltd | An orodispersible tablet of fecofenadine and it process of preparation |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
AT364354B (de) * | 1976-10-14 | 1981-10-12 | Byk Gulden Lomberg Chem Fab | Verfahren zur herstellung von neuen pyrazol-1yl-phenylessigsaeuren, deren salzen und optischen isomeren |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
KR100193121B1 (ko) * | 1990-05-23 | 1999-06-15 | 조셉 에프. 셔츠, 안드레아 엘. 콜비 | 맛 차폐 및 서방성 약제용 피복물 |
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
US5213811A (en) * | 1991-09-13 | 1993-05-25 | Sterling Drug Inc. | Oral sustained-release drug compositions |
WO1993024109A1 (en) * | 1992-06-04 | 1993-12-09 | Smithkline Beecham Corporation | Palatable pharmaceutical compositions |
IT1264020B (it) * | 1993-01-28 | 1996-09-09 | Recordati Chem Pharm | Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi |
PT812195E (pt) * | 1995-02-28 | 2003-03-31 | Aventis Pharma Inc | Composicao farmaceutica para compostos de piperidinoalcanol |
EP1380308B1 (en) * | 1996-07-12 | 2008-07-09 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
AU8699298A (en) * | 1997-08-11 | 1999-03-01 | Alza Corporation | Prolonged release active agent dosage form adapted for gastric retention |
US6117452A (en) * | 1998-08-12 | 2000-09-12 | Fuisz Technologies Ltd. | Fatty ester combinations |
FR2785538B1 (fr) * | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
US6267811B1 (en) * | 1998-12-21 | 2001-07-31 | Stora Enso North America Corp. | Talc slurry dispersion |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
KR20010006835A (ko) * | 1999-03-25 | 2001-01-26 | 김선진 | 경구용 속붕해정 |
JP3435664B2 (ja) * | 1999-12-08 | 2003-08-11 | ヤンセンファーマ株式会社 | 口腔内速崩壊型錠剤及びその製造方法 |
AU4278301A (en) * | 2000-03-27 | 2001-10-08 | Kyowa Hakko Kogyo Co. Ltd. | Easy-to-take granule |
FR2816507B1 (fr) * | 2000-11-16 | 2003-02-28 | Ethypharm Lab Prod Ethiques | Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules |
US20020119196A1 (en) * | 2000-12-21 | 2002-08-29 | Narendra Parikh | Texture masked particles containing an active ingredient |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
-
2001
- 2001-11-16 US US09/995,975 patent/US6723348B2/en not_active Expired - Lifetime
-
2002
- 2002-11-14 KR KR1020047007536A patent/KR101020809B1/ko active IP Right Grant
- 2002-11-14 WO PCT/EP2002/014917 patent/WO2003041683A2/en active Application Filing
- 2002-11-14 PL PL02368610A patent/PL368610A1/xx not_active Application Discontinuation
- 2002-11-14 KR KR1020097019922A patent/KR20090117899A/ko not_active Application Discontinuation
- 2002-11-14 HU HU0402293A patent/HU229570B1/hu unknown
- 2002-11-14 AU AU2002356786A patent/AU2002356786A1/en not_active Abandoned
- 2002-11-14 CN CN201010176984A patent/CN101849917A/zh active Pending
- 2002-11-14 JP JP2003543570A patent/JP2005513008A/ja active Pending
- 2002-11-14 CA CA2466580A patent/CA2466580C/en not_active Expired - Lifetime
- 2002-11-14 CN CNA02822602XA patent/CN1592622A/zh active Pending
- 2002-11-14 EP EP02803040A patent/EP1458387B1/en not_active Expired - Lifetime
- 2002-11-14 US US10/495,007 patent/US20050053654A1/en not_active Abandoned
- 2002-11-14 DE DE60213861T patent/DE60213861T2/de not_active Expired - Lifetime
- 2002-11-14 AT AT02803040T patent/ATE335483T1/de not_active IP Right Cessation
- 2002-11-14 ES ES02803040T patent/ES2269817T3/es not_active Expired - Lifetime
-
2005
- 2005-03-19 HK HK05102404A patent/HK1069340A1/xx not_active IP Right Cessation
-
2010
- 2010-06-01 JP JP2010125743A patent/JP5525920B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2003041683A2 (en) | 2003-05-22 |
DE60213861T2 (de) | 2007-03-08 |
JP2010184938A (ja) | 2010-08-26 |
PL368610A1 (en) | 2005-04-04 |
KR101020809B1 (ko) | 2011-03-09 |
HUP0402293A3 (en) | 2011-05-30 |
DE60213861D1 (de) | 2006-09-21 |
US20030099700A1 (en) | 2003-05-29 |
US20050053654A1 (en) | 2005-03-10 |
US6723348B2 (en) | 2004-04-20 |
HU229570B1 (en) | 2014-02-28 |
CA2466580C (en) | 2011-06-07 |
CN1592622A (zh) | 2005-03-09 |
KR20050044512A (ko) | 2005-05-12 |
AU2002356786A1 (en) | 2003-05-26 |
HK1069340A1 (en) | 2005-05-20 |
ATE335483T1 (de) | 2006-09-15 |
ES2269817T3 (es) | 2007-04-01 |
KR20090117899A (ko) | 2009-11-13 |
EP1458387B1 (en) | 2006-08-09 |
JP5525920B2 (ja) | 2014-06-18 |
JP2005513008A (ja) | 2005-05-12 |
CN101849917A (zh) | 2010-10-06 |
EP1458387A2 (en) | 2004-09-22 |
CA2466580A1 (en) | 2003-05-22 |
WO2003041683A3 (en) | 2003-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402293A2 (hu) | Fexofenadint tartalmazó szájban diszpergálódó tablettakészítmény, bevonatos granulátum és eljárás az előállítására | |
HUP0002316A2 (hu) | Gyorsan olvadó orális adagolási formák | |
HUP0303325A2 (hu) | Gyógyászati sók és ezeket tartalmazó gyógyászati készítmények | |
PT1156786E (pt) | Comprimido dispersivel oralmente com baixa friabilidade e metodo para a sua preparacao | |
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0105463A2 (hu) | Divalproex-nátriumot tartalmazó szabályozott felszabadulású készítmény | |
HUP0201877A2 (hu) | Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák | |
HUP9802999A2 (hu) | N-propargil-1-amino-indánt tartalmazó gyógyszerkészítmény | |
HUP0202495A2 (hu) | Orális alkalmazásra szolgáló stabil gyógyszerkészítmény | |
HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
HUP0000138A2 (hu) | Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények | |
HUP0301400A2 (hu) | Gyógyszerösszetétel és adagolási forma az alendronát és/vagy más biszfoszfonátoknak a gyomorban történż késleltetett felszabadulására | |
AU3731699A (en) | Orally disintegrable tablets | |
HUP0401941A2 (hu) | Protonpumpa inhibitort és savmegkötőket tartalmazó gyógyszerforma és eljárás az előállítására | |
HUP0101411A2 (hu) | 2-es típusú angiotenzin II receptor agonistákat tartalmazó gyógyszerkészítmények és ezek alkalmazása | |
ATE454132T1 (de) | Rasch in der mundhöhle schmelzende tablette | |
HK1087336A1 (en) | Pharmaceutical composition comprising lumiracoxib | |
HUP0401569A2 (hu) | Amlodipint és atorvastatint tartalmazó gyógyászati készítmények és eljárás az előállításukra | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
HUP0402492A2 (hu) | 5HT4 részleges agonistát tartalmazó gyógyszerkészítmények | |
HUP0402577A2 (hu) | Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra | |
BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
HUP0400127A2 (hu) | Paracetamolt tartalmazó lenyelhető tabletta | |
MXPA04003346A (es) | Formulacion de dosis oral de disolucion instantanea. | |
HUP0105308A2 (hu) | Eletriptán-hidrobromid-monohidrát, eljárás az előállítására és a vegyületet tartalmazó gyógyszerkészítmények |